GENE ONLINE|News &
Opinion
Blog

Feature
COVID-19
Taiwan Identifies Five Potential COVID-19 Drugs from 3,000 Existing Medicines
2021-01-31
COVID-19 Vaccine
Johnson & Johnson’s COVID-19 Vaccine Draws Mixed Reactions as it Registers 66% Efficacy
2021-01-31
COVID-19 Anti-COVID Drug
Japan’s Shionogi Grants US Company the Rights to Develop a Repurposed Allergic Rhinitis Drug as a COVID-19 Cure
2021-01-29
COVID-19 COVID-19 Variant
Novavax’s Protein Subunit Vaccine Shows 89.3% Efficacy in Phase 3 UK Trial
2021-01-29
COVID-19
Asia Microbiome Conference Highlights: COVID-19 Variants, New Strain Culturing, and Upcoming Trends
2021-01-28Partner
COVID-19 COVID-19 Variant
Lilly Teams up with GSK, Vir to Fight New COVID-19 Variants Using Antibody Combo
2021-01-28
COVID-19 Summer Olympics
With Olympics Just Months Away, Japan Plans for COVID-19 Vaccinations and Testing
2021-01-27
COVID-19
Regeneron Looks to Achieve “Passive Vaccination” with COVID-19 Antibody Cocktail
2021-01-27
COVID-19
Moderna Applies Two-Pronged Strategy to Fight against Coronavirus Variants 
2021-01-26
COVID-19 Vaccine
Merck Withdraws from COVID-19 Vaccine Race Due to Sub-par Response
2021-01-25
COVID-19 Quarantine Units
Expecting Lunar New Year Travel Rush, China Races to Build Giant Quarantine Center
2021-01-24
COVID-19 Antibody
Lilly’s Antibody Treatment Prevents COVID-19 Spread at Nursing Home
2021-01-23
COVID-19 Antigen Test
COVID-19: LumiraDx’s Antigen Test Gets Approved in Two More Countries
2021-01-22
COVID-19
Thermo Fisher Expands Portfolio by Acquiring COVID-19 Diagnostic Company
2021-01-20
COVID-19 mRNA Vaccine
COVID-19: Another Study Suggests Pfizer/BioNTech Vaccine is Capable of Neutralizing UK Variant
2021-01-20
1 … 40 41 42 43 44 … 60
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top